Free Trial

Brainsway (BWAY) Competitors

Brainsway logo
$15.32 +0.17 (+1.12%)
As of 10:04 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BWAY vs. KMTS, ESTA, MDXG, INMD, TNDM, BBNX, IRMD, EMBC, CLPT, and AXGN

Should you be buying Brainsway stock or one of its competitors? The main competitors of Brainsway include Kestra Medical Technologies (KMTS), Establishment Labs (ESTA), MiMedx Group (MDXG), InMode (INMD), Tandem Diabetes Care (TNDM), Beta Bionics (BBNX), iRadimed (IRMD), Embecta (EMBC), ClearPoint Neuro (CLPT), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry.

Brainsway vs. Its Competitors

Brainsway (NASDAQ:BWAY) and Kestra Medical Technologies (NASDAQ:KMTS) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

Brainsway has a net margin of 11.60% compared to Kestra Medical Technologies' net margin of 0.00%. Brainsway's return on equity of 8.97% beat Kestra Medical Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Brainsway11.60% 8.97% 5.65%
Kestra Medical Technologies N/A N/A N/A

In the previous week, Brainsway had 1 more articles in the media than Kestra Medical Technologies. MarketBeat recorded 5 mentions for Brainsway and 4 mentions for Kestra Medical Technologies. Brainsway's average media sentiment score of 0.63 beat Kestra Medical Technologies' score of 0.55 indicating that Brainsway is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Brainsway
0 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Kestra Medical Technologies
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

30.1% of Brainsway shares are owned by institutional investors. 19.0% of Brainsway shares are owned by company insiders. Comparatively, 3.6% of Kestra Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Brainsway has higher earnings, but lower revenue than Kestra Medical Technologies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Brainsway$41.02M7.10$2.92M$0.2658.92
Kestra Medical Technologies$66.40M17.86-$113.81MN/AN/A

Brainsway presently has a consensus price target of $18.00, indicating a potential upside of 17.49%. Kestra Medical Technologies has a consensus price target of $27.33, indicating a potential upside of 18.58%. Given Kestra Medical Technologies' higher possible upside, analysts plainly believe Kestra Medical Technologies is more favorable than Brainsway.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Brainsway
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Kestra Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Summary

Brainsway beats Kestra Medical Technologies on 9 of the 13 factors compared between the two stocks.

Get Brainsway News Delivered to You Automatically

Sign up to receive the latest news and ratings for BWAY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BWAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BWAY vs. The Competition

MetricBrainswayMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$291.08M$10.45B$6.04B$10.53B
Dividend YieldN/A1.89%5.73%4.80%
P/E Ratio58.9321.1084.5127.54
Price / Sales7.1036.60513.90198.23
Price / Cash60.8025.0637.5761.53
Price / Book4.633.4812.286.84
Net Income$2.92M$210.63M$3.32B$276.59M
7 Day Performance-1.29%-0.12%-0.30%0.64%
1 Month Performance1.46%3.71%9.36%8.73%
1 Year Performance64.38%-3.84%72.91%35.73%

Brainsway Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BWAY
Brainsway
3.3953 of 5 stars
$15.32
+1.1%
$18.00
+17.5%
+61.3%$291.08M$41.02M58.93120News Coverage
Analyst Forecast
KMTS
Kestra Medical Technologies
1.3635 of 5 stars
$22.58
+2.6%
$27.33
+21.1%
N/A$1.13B$59.81M0.00300Gap Up
ESTA
Establishment Labs
2.5599 of 5 stars
$41.16
+5.7%
$56.50
+37.3%
+7.6%$1.13B$166.02M-13.501,018News Coverage
MDXG
MiMedx Group
3.4285 of 5 stars
$6.51
-0.6%
$12.00
+84.3%
+14.8%$969.13M$348.88M31.00870News Coverage
INMD
InMode
2.674 of 5 stars
$15.30
+0.2%
$18.21
+19.0%
-7.3%$964.89M$394.82M6.19480
TNDM
Tandem Diabetes Care
4.2191 of 5 stars
$13.87
-0.9%
$22.69
+63.6%
-61.5%$945.97M$940.20M-4.492,650
BBNX
Beta Bionics
1.7732 of 5 stars
$22.15
+5.3%
$24.44
+10.4%
N/A$914.18M$65.12M0.00294
IRMD
iRadimed
4.5743 of 5 stars
$72.41
+1.0%
$72.00
-0.6%
+45.4%$911.42M$73.24M44.70110News Coverage
Insider Trade
EMBC
Embecta
4.6013 of 5 stars
$13.35
-0.2%
$19.00
+42.3%
+3.4%$782.53M$1.12B9.342,100
CLPT
ClearPoint Neuro
0.8342 of 5 stars
$26.27
+0.6%
$19.67
-25.1%
+109.8%$742.24M$31.39M-32.43110Insider Trade
Gap Up
AXGN
AxoGen
3.0468 of 5 stars
$15.59
-2.5%
$25.75
+65.2%
+11.4%$735.74M$187.34M-155.88450

Related Companies and Tools


This page (NASDAQ:BWAY) was last updated on 10/15/2025 by MarketBeat.com Staff
From Our Partners